HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Attilio Orazi Selected Research

Thrombopoietin Receptors

7/2015Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the EXTEND study.
5/2014Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up.
1/2012Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities.
10/2011Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Attilio Orazi Research Topics

Disease

15Neoplasms (Cancer)
12/2015 - 01/2004
15Primary Myelofibrosis (Myelosclerosis)
10/2015 - 05/2005
13Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
12/2015 - 06/2006
11Fibrosis (Cirrhosis)
10/2015 - 12/2004
6Lymphoma (Lymphomas)
02/2015 - 08/2004
4Essential Thrombocythemia
10/2015 - 10/2013
4Polycythemia Vera
10/2015 - 10/2013
4Thrombocytopenia (Thrombopenia)
07/2015 - 10/2011
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2015 - 01/2005
3Chromosome Aberrations (Chromosome Abnormalities)
11/2009 - 05/2005
2Splenomegaly
05/2015 - 07/2009
2Myeloproliferative Disorders (Myeloproliferative Disorder)
08/2014 - 12/2005
2Multiple Myeloma
03/2014 - 07/2002
2Hematologic Neoplasms (Hematological Malignancy)
11/2010 - 01/2007
2Systemic Mastocytosis
11/2010 - 07/2009
2Trisomy (Trisomies)
12/2009 - 01/2005
2Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2009 - 06/2006
2Thrombotic Thrombocytopenic Purpura
12/2005 - 04/2004
1Osteosclerosis
05/2015
1Disease Progression
03/2015
1Genetic Translocation (Chromosomal Translocation)
10/2014
1B-Cell Leukemia (Leukemia, B Cell)
06/2014
1Necrotizing Fasciitis
03/2014
1Histiocytic Sarcoma
04/2011
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2010
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2009
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2009
1Pancytopenia
07/2009
1Rheumatoid Arthritis
07/2009
1Fever (Fevers)
07/2009
1Visceral Leishmaniasis (Kala Azar)
07/2009
1Infection
07/2009
1Opportunistic Infections (Opportunistic Infection)
07/2009
1Polycythemia (Erythrocytosis)
08/2007
1Thrombocytosis (Thrombocythemia)
08/2007
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2006
1Branchioma (Branchial Cleft Cysts)
08/2006
1Myelolipoma
07/2006

Drug/Important Bio-Agent (IBA)

12rituximab (Mabthera)FDA Link
12/2015 - 06/2006
9Reticulin (Reticular Fiber)IBA
07/2015 - 12/2004
6CollagenIBA
05/2015 - 08/2005
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2015 - 10/2012
4Prednisone (Sone)FDA LinkGeneric
10/2015 - 10/2012
4Vincristine (Oncovin)FDA LinkGeneric
10/2015 - 10/2012
4Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
08/2015 - 09/2005
4Thrombopoietin ReceptorsIBA
07/2015 - 10/2011
3Phosphotransferases (Kinase)IBA
09/2015 - 10/2013
3Cyclin D1IBA
06/2014 - 01/2005
3ParaffinIBA
10/2012 - 07/2006
3AntibodiesIBA
01/2007 - 07/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2015 - 10/2012
2InterferonsIBA
10/2015 - 10/2012
2Biological Markers (Surrogate Marker)IBA
10/2014 - 03/2008
2Janus Kinase 2IBA
10/2013 - 08/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2009 - 05/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2008 - 06/2006
2AntigensIBA
01/2007 - 05/2005
1Inhibitor of Apoptosis ProteinsIBA
10/2015
1VAP-cyclo protocolIBA
10/2015
1lestaurtinibIBA
09/2015
1eltrombopagFDA Link
07/2015
1MicroRNAs (MicroRNA)IBA
06/2015
1INCB018424IBA
05/2015
1CXCR4 Receptors (CXCR4 Receptor)IBA
03/2015
1CyclinsIBA
02/2015
1carboxyl radical (COO-)IBA
10/2014
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2014
1RC 101IBA
08/2014
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
06/2014
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2014
1Immunoglobulin G (IgG)IBA
03/2014
1ChromatinIBA
12/2013
13' Untranslated Regions (3' UTR)IBA
05/2013
1Thrombopoietin (c-mpl Ligand)IBA
10/2012
1CytokinesIBA
10/2011
1Inosine Triphosphate (ITP)IBA
10/2011
1Thalidomide (Thalomid)FDA Link
04/2011
1Carbon MonoxideIBA
11/2010
1Tryptases (Tryptase)IBA
11/2010
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
12/2009
1tebufenozide (Mimic)IBA
11/2009
1monosomy Chromosome 7IBA
11/2009
15q- syndromeIBA
08/2009
1Collagen Type IV (Type IV Collagen)IBA
07/2009
1Laminin (Merosin)IBA
07/2009
1Adrenal Cortex Hormones (Corticosteroids)IBA
07/2009
1Methotrexate (Mexate)FDA LinkGeneric
07/2009
1Vascular Endothelial Growth Factor CIBA
03/2008
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2008
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
08/2006
1Hemoglobins (Hemoglobin)IBA
07/2006
1Hematoxylin (Haematoxylon)IBA
07/2006
1Peroxidase (Myeloperoxidase)IBA
07/2006
1Formaldehyde (Formol)FDA Link
07/2006
1Monoclonal AntibodiesIBA
07/2006
1Eosine Yellowish-(YS) (Eosin)IBA
07/2006

Therapy/Procedure

2Hematopoietic Stem Cell Transplantation
08/2014 - 04/2011
2Transplants (Transplant)
10/2013 - 12/2005
1Radiotherapy
07/2014
1Investigational Therapies (Experimental Therapy)
10/2013